ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 253 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $171,642 | -60.6% | 31,494 | -51.5% | 0.00% | – |
| Q2 2023 | $436,049 | -30.9% | 64,985 | -9.1% | 0.00% | -100.0% |
| Q1 2023 | $631,213 | -9.3% | 71,485 | -21.5% | 0.00% | 0.0% |
| Q4 2022 | $696,149 | +11.6% | 91,119 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $624,000 | -15.3% | 91,119 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $737,000 | -41.7% | 91,119 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $1,265,000 | -75.0% | 91,119 | -49.4% | 0.00% | -75.0% |
| Q4 2021 | $5,053,000 | +23.9% | 180,072 | +50.1% | 0.00% | 0.0% |
| Q3 2021 | $4,078,000 | -2.5% | 119,972 | +5.2% | 0.00% | 0.0% |
| Q2 2021 | $4,182,000 | +3.5% | 114,072 | +13.6% | 0.00% | -20.0% |
| Q1 2021 | $4,041,000 | +5.7% | 100,375 | +55.2% | 0.01% | 0.0% |
| Q4 2020 | $3,823,000 | +69.2% | 64,656 | +39.2% | 0.01% | +66.7% |
| Q3 2020 | $2,259,000 | +0.5% | 46,456 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $2,248,000 | +78.4% | 46,456 | +2.4% | 0.00% | +50.0% |
| Q1 2020 | $1,260,000 | +56.9% | 45,356 | +69.0% | 0.00% | +100.0% |
| Q4 2019 | $803,000 | +3.3% | 26,832 | +6.8% | 0.00% | 0.0% |
| Q3 2019 | $777,000 | – | 25,132 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
| Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
| Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
| Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
| TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
| Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
| Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
| Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
| Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |